| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.063 | 0.09 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.19 | 0.09 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.09 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |